Patients with PD-L1 and PD-1 positive tumors had a lower OS than patients with PD-L1 and PD-1 negative tumors, though the difference did not reach statistical significance ( p = 0.14) ( Figure 4 d).
← all excerpts
Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC).
1
0.1400
0.1400